Literature DB >> 11844704

Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase.

Mui Mui Sim1, Siew Bee Ng, Antony David Buss, Sharon Carmelita Crasta, Kah Lin Goh, Sue Kim Lee.   

Abstract

Benzylidene rhodanines are novel inhibitors of UDP N-acetylmuramate/L-alanine ligase. They showed selective whole-cell activity against the Gram-positive MRSA but not against the Gram-negative Escherichia coli. Their cytotoxic effect on mammalian CHO cells was also evaluated.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11844704     DOI： 10.1016/s0960-894x(01)00832-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  14 in total

1.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

2.  Testing the ability of rhodanine and 2, 4-thiazolidinedione to interact with the human pancreatic alpha-amylase: electron-density descriptors complement molecular docking, QM, and QM/MM dynamics calculations.

Authors:  Rajendran Niranjana Devi; Maria G Khrenova; Samuel Israel; Chellam Anzline; Andrey A Astakhov; Vladimir G Tsirelson
Journal:  J Mol Model       Date:  2017-08-05       Impact factor: 1.810

3.  An efficient microwave assisted synthesis of novel class of Rhodanine derivatives as potential HIV-1 and JSP-1 inhibitors.

Authors:  Sukanta Kamila; Haribabu Ankati; Edward R Biehl
Journal:  Tetrahedron Lett       Date:  2011-08-24       Impact factor: 2.415

Review 4.  Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.

Authors:  Gleiciane Leal Moraes; Guelber Cardoso Gomes; Paulo Robson Monteiro de Sousa; Cláudio Nahum Alves; Thavendran Govender; Hendrik G Kruger; Glenn E M Maguire; Gyanu Lamichhane; Jerônimo Lameira
Journal:  Tuberculosis (Edinb)       Date:  2015-01-29       Impact factor: 3.131

5.  Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers.

Authors:  Samuel Attah Egu; Irfan Ali; Khalid Mohammed Khan; Sridevi Chigurupati; Urooj Qureshi; Uzma Salar; Muhammad Taha; Shatha Ghazi Felemban; Vijayan Venugopal; Zaheer Ul-Haq
Journal:  Mol Divers       Date:  2022-05-23       Impact factor: 2.943

6.  Synthesis and Anti-Cancer Activity of New Pyrazolinyl-Indole Derivatives: Pharmacophoric Interactions and Docking Studies for Identifying New EGFR Inhibitors.

Authors:  Habibullah Khalilullah; Deepak K Agarwal; Mohamed J Ahsan; Surender S Jadav; Hamdoon A Mohammed; Masood Alam Khan; Salman A A Mohammed; Riaz Khan
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

Review 7.  Recent pharmacological developments on rhodanines and 2,4-thiazolidinediones.

Authors:  Ravinder Singh Bhatti; Sakshi Shah; Pawan Krishan; Jagir S Sandhu
Journal:  Int J Med Chem       Date:  2013-05-02

8.  Catalyst-free synthesis of highly biologically active 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol.

Authors:  Dhruva Kumar; Suresh Narwal; Jagir S Sandhu
Journal:  Int J Med Chem       Date:  2013-02-14

9.  Synthesis and Antibacterial Evaluation of (S,Z)-4-methyl-2-(4-oxo-5-((5-substituted phenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)Pentanoic Acids.

Authors:  Ming-Xia Song; Xian-Qing Deng; Zhi-Yu Wei; Chang-Ji Zheng; Yan Wu; Chang-Shan An; Hu-Ri Piao
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Novel Rhodanine Derivative, 5-[4-(4-Fluorophenoxy) phenyl]methylene-3-{4-[3-(4-methylpiperazin-1-yl) propoxy]phenyl}-2-thioxo-4-thiazolidinone dihydrochloride, Induces Apoptosis via Mitochondria Dysfunction and Endoplasmic Reticulum Stress in Human Colon Cancer Cells.

Authors:  Hye-Uk Jung; Jeong-Hun Lee; Kyung-Sook Chung; Joo Young Hong; Jung-Hye Choi; Soo-Dong Kim; Eun Joo Roh; Kye Jung Shin; Kyung-Tae Lee
Journal:  Molecules       Date:  2018-11-06       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.